US Patent Issued to AMGEN RESEARCH (MUNICH) on April 22 for "Cross-species-specific PSMAxCD3 bispecific single chain antibody" (German, Swiss Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,281,172, issued on April 22, was assigned to AMGEN RESEARCH (MUNICH) GMBH (Munich).

"Cross-species-specific PSMAxCD3 bispecific single chain antibody" was invented by Peter Kufer (Moosburg an der Isar, Germany), Tobias Raum (Eurasburg, Germany), Roman Kischel (Munich), Ralf Lutterbuse (Neuried, Germany), Patrick Hoffmann (Bad Heilbrunn, Germany), Doris Rau (Munich), Susanne Mangold (Cham, Switzerland), Matthias Klinger (Gilching, Germany), Evelyne Schaller (Munich), Susanne Hausmann (Sauerlach, Germany), Petra Fluhr (Dachau, Germany) and Carola Steiger (Augsburg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a bi...